Inherited risk factors for venous thromboembolism: implications for clinical practice (Q33912473)

30 July 2017

1 reference

title

Inherited risk factors for venous thromboembolism: implications for clinical practice. (English)

1 reference

30 July 2017

main subject

venous thromboembolism

1 reference

P M Ridker

1

1 reference

30 July 2017

publication date

1 January 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

2

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

1-14

1 reference

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(00)95009-7

7 January 2021

Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(00)95009-7

7 January 2021

Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(00)95009-7

7 January 2021

The Risk of Recurrent Venous Thromboembolism in Patients with an Arg506→Gln Mutation in the Gene for Factor V (Factor V Leiden)

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(00)95009-7

7 January 2021

Factor V Leiden and Risks of Recurrent Idiopathic Venous Thromboembolism

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(00)95009-7

7 January 2021

Factor V Leiden Mutation and the Risks for Thromboembolic Disease: A Clinical Perspective

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(00)95009-7

7 January 2021

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(00)95009-7

7 January 2021

Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(00)95009-7

7 January 2021

Factor V Leiden Mutation as a Risk Factor for Recurrent Pregnancy Loss

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(00)95009-7

7 January 2021

G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(00)95009-7

7 January 2021

The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin Mutation

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(00)95009-7

7 January 2021

Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(00)95009-7

7 January 2021

Venous thrombosis: a multicausal disease

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(00)95009-7

7 January 2021

A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(00)95009-7

7 January 2021

The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(00)95009-7

7 January 2021

A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(00)95009-7

7 January 2021

Long-term, low-dose warfarin among venous thrombosis patients with and without factor V Leiden mutation: rationale and design for the Prevention of Recurrent Venous Thromboembolism (PREVENT) trial

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(00)95009-7

7 January 2021

10.1016/S1098-3597(00)95009-7

Identifiers

DOI

1 reference

30 July 2017

1 reference